STIPENDS AND AWARDS - USCAP Meeting...STIPENDS AND AWARDS ... Chemotherapy for Bladder Cancer: Is Tumor Regression Important? Mayo Clinic, Rochester, MN. Andrew McDaniel, MD, PhD [970]

STIPENDS AND AWARDS

Adeboye O. Osunkoya, MD, Awards Committee Chair, ISUP

Stipend Awards : Samson Fine, MD, Chair

Grawitz Medal Presentation Koss Medal Presentation

2015 Excellence in Urologic Pathology

Resident/Fellow Research Award

Adeboye O. Osunkoya, MD, Award Committee Chair, ISUP

Peter A. Humphrey, MD, PhD, President, ISUP

Dan Berney, MA, MB BChir, Secretary, ISUP

Nooshin K. Dashti, MD

[928] Dashti NK, et al. The Pathologic Features in Radical Cystectomy Specimens of Patients Receiving Neoadjuvant

Chemotherapy for Bladder Cancer: Is Tumor Regression Important?

Mayo Clinic, Rochester, MN.

Andrew McDaniel, MD, PhD

[970] McDaniel A, et al. Targeted Genomic Profiling of Penile Squamous Cell Carcinoma Reveals

Opportunities for Targeted Therapy. University of Michigan Medical School, Ann Arbor, MI.

Qinghu Ren, MD, PhD

[1012] Ren Q, et al. Upper Tract Urothelial Carcinoma: Genetic Characteristics and Correlation With

Morphology and Clinical Outcomes. Memorial Sloan Kettering Cancer Center, New York, NY.

Acknowledgement

Mahul B. Amin, MDCedars-Sinai Medical Center, Los Angeles, CA.

Jonathan I. Epstein, MDThe Johns Hopkins Hospital, Baltimore, MD.

2015 Judges

ISUP STIPEND AWARD WINNERS

Presented by Samson Fine, MD

ISUP Stipend Awardees

Dr. Martin Braun Dr. Kuo-Cheng (David) Huang Dr. Carmen Perrino Dr. Aaron Udager

Chosen from among a record 43 qualified candidates

GRAWITZ AWARD

Dr. Samson Fine

Dr. Leopold George Koss

Diagnostic Cytology and Its HistopathologicBases, 5th rev. edition 2006

AFIP Fascicle Tumors of the Urinary Bladder, 1975

KOSS MEDAL AWARD

Dr. Guido Martignoni

PRESIDENT LARS EGEVAD

ISUP COMPANION MEETING 2015

7:00 pm Companion Meeting Moderators : HemamaliSamaratunga, MBBS, FRCPA, University of Queensland, Brisbane, Australia and Jesse McKenney, MD, Cleveland Clinic, Cleveland, OH

7:00 pm Introduction and President's Remarks : Lars Egevad, MD, Karolinska Institute, Stockholm, Sweden

7:15 pm Update on Prostate Cancer Grading, with Introduction of a New Grading System : Jonathan Epstein, MD, The Johns Hopkins Hospital, Baltimore, MD

8:00 pm Non-Gleason Aspects of Active Surveillance : Peter Humphrey, MD, Yale University, New Haven, CT

8:45 pm Papillary and Pseudo-Papillary Tumors of the Kidney : Ming Zhou, MD, PhD, Tisch Hospital, New York, NY

9:30 pm Adrenal Pathology: A Urological Pathologist’s Perspective : Donna Hansel, MD, PhD, University of California San Diego, San Diego, CA

10:15 pm Concluding Remarks